References
- Sokoloff P., Giros B., Marpres M. P., Bouthenet M. L., Schwartz J. C. Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990; 347: 146–151
- Sunhara R. K., Guan H.-C., O'Dowd B. F., Seeman P., Laurier L. G., Ng G., George S. R., Torchia J., Van Tol H. M. H., Niznik H. B. Cloning of the gene for a human D5 receptor with higher affinity for dopamine than D1. Nature 1991; 350: 614–619
- Van Tol H. M. H., Bunzow J. R., Guan H.-C., Sunhara R. K., Seeman P., Niznik H. B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350: 610–614
- Stoof J. C., Kebabian J. W. Opposing roles for D1 and D2 dopamine receptors in the efflux of cyclic AMP from rat neostriatum. Nature 1982; 294: 366–368
- Rupniak N. M. J., Jenner P. G., Marsden C. D. Long-term neuroleptic treatment and the status of the dopamine hypothesis of schizophrenia. Theory in Psychpharmacology, S. J. Cooper. Academic Press, London 1983; 195–237
- Hess E. J., Albers L. J., Le H., Creese I. Effects of chronic SCH 23390 treatment on the biochemical and behavioural properties of D1 and D2 dopamine agonists after selective D1 dopamine receptor up-regulation. J. Pharmacol. Exp. Ther. 1986; 238: 846–854
- Memo M., Pizzi M., Nisoli E., Missale C., Carruba M. O., Spano P. F. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D1 and D2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions. Eur. J. Pharmacol. 1987; 138: 45–51
- Olianas M. C., Onali P. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic treatment of haloperidol in mice. Neurosci. Lett. 1987; 78: 349–354
- Memo M., Pizzi M., Missale C., Carruba M. O., Spano P. F. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens in rats treated chronically with haloperidol. Neuropharmacology 1987; 26: 477–480
- De Keyser J., Dierckx R., Vanderheyden P., Ebinger G., Vauquelin G. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation. Brain Res. 1988; 443: 77–84
- Kelly E., Willcocks A. L., Nahorski S. R. Neurochemical and behavioural evidence that dopamine D2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmacol. 1987; 335: 618–623
- Seeman P., Ulpian C., Grigoriadis D., Pri-Bar I., Buchman O. Conversion of dopamine D1 receptors from high to low affinity for dopamine. Biochem. Pharmacol. 1985; 34: 151–154
- O'Boyle K. M., Waddington J. L. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity. Neuropharmacology 1992; 31: 177–183
- Farrell C. B., O'Boyle K. M. Interaction of dopamine with rat striatal D1 receptors: influence of Gpp(NH)p. Ir. J. Med. Sci.
- O'Boyle K. M., Waddington J. L. 3H-SCH 23390 binding to human putamen D1 dopamine receptors: stereochemical and structure affinity relationships among 1-phenyl-1H-3-benzazepine derivatives as a guide to receptor topography. J. Neurochem. 1987; 48: 1039–1042
- O'Boyle K. M., Waddington J. L. Selective and stereospecific interactions of R-SK&F 38393 with 3H-piflutixol but not 3H-spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. Eur. J. Pharmacol. 1984; 98: 433–436
- Barlow R. B. Biodata Handling with Microcomputers. Elsevier, Amsterdam 1983
- Sibley D. R., Creese I. Pseudo non-competitive agonist interactions with dopamine receptors. Eur. J. Pharmacol. 1980; 65: 131–133
- Chatterjee T. K., Scott C. E., Vazquez D. M., Bhatnager R. K. Interaction of 3H-spiperone with rat striatal D2 dopamine receptors: kinetic evidence for antagonist formation of ternary complex. Molec. Pharmacol. 1988; 33: 402–413
- Rothman R. B., Westfall T. C. Allosteric modulation by leucine-enkephalin of 3H-naloxone binding in rat brain. Eur. J. Pharmacol. 1981; 72: 356–368
- DeLean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the agonist-occupied beta-adrenergic receptor. J. Biol. Chem. 1980; 255: 7108–7117